Skip to main content
. 2020 Oct 23;163(4):937–945. doi: 10.1007/s00701-020-04623-z

Table 5.

Survival analyses

Entire cohort Surgical resection Biopsy
N % N % N % p
Patients 55 100 25 45.5 30 54.5 -
  Median OS (CI 95%) 252 (123–513) 258 (153–413) 220 (244–NA) 0.041
  Median PFS 153 146 154
  3-month survival 42 76 21 84 21 78 n.s.
  6-month survival 32 58 16 67 16 59 n.s.
  12-month survival 21 38 12 58 9 33 0.032
  24-month survival 5 9 3 30 2 7 0.047

OS, overall survival; PFS, progression-free survival; n.s., not significant